New England Journal of Medicine
Polypill with or without Aspirin in Persons without Cardiovascular Disease
The Lancet
Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomized controlled trials
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
JAMA Internal Medicine
Time to Benefit of Statin Therapy for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 Years
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomized, open-label, phase 3b trial
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
Review highlights from the recent CMHC Masterclass
Addressing the NAFLD/NASH Epidemic: Advances in Pathophysiology, Diagnosis and Management
January 8-9, 2021
Addressing Cardiometabolic Risk in Children and Adolescents: Challenges and Solutions
January 28-29, 2021
Cardiometabolic Health Congress, 1801 North Military, Suite 200, Boca Raton, Florida 33431, United States, 877.571.4700
Unsubscribe Manage preferences
